SpringWorks Therapeutics to Present at Upcoming Investor Conferences
SpringWorks Therapeutics, Inc. (SWTX) will present at investor conferences including TD Cowen 44th Annual Health Care Conference and Barclays 26th Annual Global Healthcare Conference. Webcasts will be available on the company's website.
02/22/2024 - 07:00 AM
STAMFORD, Conn., Feb. 22, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that management will present at the following investor conferences:
TD Cowen 44th Annual Health Care Conference on Monday, March 4 at 2:50 p.m. E.T. Barclays 26th Annual Global Healthcare Conference on Tuesday, March 12 at 9:00 a.m. E.T. Webcasts of these events will be available on the Events & Presentations page within the Investors & Media section of the company’s website at https://ir.springworkstx.com
About SpringWorks Therapeutics
SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer.
Founded in 2017, SpringWorks has a diversified targeted oncology pipeline spanning solid tumors and hematological cancers, including clinical trials in rare tumor types and highly prevalent, genetically defined cancers. OGSIVEO™, approved in the United States for the treatment of adult patients with progressing desmoid tumors who require systemic treatment, is SpringWorks’ first FDA-approved therapy. SpringWorks’ strategic approach and operational excellence in clinical development have enabled it to rapidly advance its lead product candidates into late-stage trials and enter into multiple collaborations with innovators in industry and academia to unlock the full potential for its portfolio and create more solutions for patients with cancer.
For more information, visit www.springworkstx.com @SpringWorksTx LinkedIn YouTube
Contacts: kdiamond@springworkstx.com
Samantha Hilson Sandler samantha.sandler@springworkstx.com
When will SpringWorks Therapeutics present at the TD Cowen 44th Annual Health Care Conference?
SpringWorks Therapeutics will present at the TD Cowen 44th Annual Health Care Conference on Monday, March 4 at 2:50 p.m. E.T.
Where can I watch the webcasts of the investor conferences?
Webcasts of the investor conferences will be available on the Events & Presentations page within the Investors & Media section of SpringWorks Therapeutics' website at https://ir.springworkstx.com.
Will there be replays of the webcasts available?
Replays of the webcasts will be available on SpringWorks Therapeutics' website for a limited time following each conference.
SpringWorks Therapeutics Inc
SWTX Rankings
#2681 Ranked by Stock Gains
SWTX Stock Data
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Tags
Health Technology, Pharmaceuticals: Major, Manufacturing, Biological Product (except Diagnostic) Manufacturing
Country
US
City
Stamford
About SWTX
springworks therapeutics is a mission-driven medicines company dedicated to developing innovative potential new treatments for unserved and underserved patient communities. originally conceived by pfizer, springworks presents a groundbreaking new model for collaboration rooted in connecting scientists, biopharmaceutical partners, patient groups, funders and philanthropists to advance and deliver transformative science to patients. through our partnerships, we remain focused on providing innovative treatments an additional avenue for development, with our launch pipeline focused on advancing potential programs for four diseases, all of which currently have no cure, including desmoid tumor, neurofibromatosis, hereditary xerocytosis and post-traumatic stress disorder. our name is a reflection of our approach to drug development: we’re springing into action to deliver treatments to people who are in great need and without alternatives.
